about
Interferon-inducible chemokines reflect severity and progression in sarcoidosisInterleukin-2 Receptor and Angiotensin-Converting Enzyme as Markers for Ocular SarcoidosisElevated 1, 25-dihydroxyvitamin D levels are associated with protracted treatment in sarcoidosis.Circulating cytokines in sarcoidosis: phenotype-specific alterations for fibrotic and non-fibrotic pulmonary disease.Calcium and vitamin D in sarcoidosis: how to assess and manageThe Diagnosis, Differential Diagnosis, and Treatment of SarcoidosisUp-to-date in pulmonary and extrapulmonary sarcoidosis.Familial vs. sporadic sarcoidosis: BTNL2 polymorphisms, clinical presentations, and outcomes in a French cohort.The Clinical Features of Sarcoidosis: A Comprehensive Review.Functional Toll-Like Receptor 9 Expression and CXCR3 Ligand Release in Pulmonary Sarcoidosis.Serum soluble interleukin-2 receptor level is more sensitive than angiotensin-converting enzyme or lysozyme for diagnosis of sarcoidosis and may be a marker of multiple organ involvement.Inhaled vasoactive intestinal peptide exerts immunoregulatory effects in sarcoidosis.The clinical and immunologic features of pulmonary fibrosis in sarcoidosis.[Granulomatous lung and systemic diseases].Sarcoidosis: a review for the internist.Diagnostic value of strain echocardiography, galectin-3, and tenascin-C levels for the identification of patients with pulmonary and cardiac sarcoidosis.Prognostic markers of sarcoidosis: an analysis of patients from everyday pneumological practice.CTAS: a CT score to quantify disease activity in pulmonary sarcoidosis.Factors signifying gender differences in clinical presentation of sarcoidosis among Estonian population.Role of serum immunoglobulins for predicting sarcoidosis outcome: A cohort study.Epidemiology of sarcoidosis: current findings and future directionsYKL-40, Soluble IL-2 Receptor, Angiotensin Converting Enzyme and C-Reactive Protein: Comparison of Markers of Sarcoidosis Activity
P2860
Q34248475-8C971532-3608-4433-9217-14E2215F36DEQ35901288-E28210C8-670B-4A64-939B-1A413E2E1D78Q36652857-E0488DC0-603B-44FB-8899-EEB6333AC82CQ36738614-625CAADB-E007-4214-BC7B-CDC466E24C0AQ36924965-E6571AB7-BB92-4FE7-8BF6-88502090936DQ37241249-E7D743DB-6FD9-4DE9-A4A3-04464F4859F2Q37377865-CE5126D5-5652-41F2-BA35-3C1D2DC84C51Q37470312-31485FA3-6818-46E0-B95A-E601A62EE23EQ38255985-0D40F2BC-566D-42F1-B858-A36D29873330Q38290398-C8A5A28D-E889-461E-A747-0410DA9A6110Q38906817-2E13E77A-2C66-4ABE-8DD9-6EC6B5BED686Q39876461-9FFFF2EF-6A2B-4471-97A3-6FCC91CE11FAQ41862598-12CF74E9-E83E-497F-ACA6-4C65AE1C4927Q45400928-771BFCE6-7AAE-4211-8C9C-506381EB54E1Q47665654-A5AF28D6-53FE-4195-BB0C-21946113AB90Q50618523-90BF537C-807F-4F40-B62A-D8D371EC8F4FQ51141920-B1883002-77C3-4B10-BB90-8D20474D6D00Q51446576-5CDFC4BF-CB68-459A-893E-BB370E6DF142Q51572961-41FB8AA5-A4A1-4B2F-BE2A-8073986DDB92Q54974263-086A79EB-531E-4C88-9D75-52B9A982F8A2Q58564538-37728E7F-00D7-4BD8-862D-374039D4330EQ58697264-5F60D9BB-806B-4CB8-A8F3-DC7DB34FE60C
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Phenotyping sarcoidosis from a pulmonary perspective.
@en
Phenotyping sarcoidosis from a pulmonary perspective.
@nl
type
label
Phenotyping sarcoidosis from a pulmonary perspective.
@en
Phenotyping sarcoidosis from a pulmonary perspective.
@nl
prefLabel
Phenotyping sarcoidosis from a pulmonary perspective.
@en
Phenotyping sarcoidosis from a pulmonary perspective.
@nl
P2093
P2860
P50
P1476
Phenotyping sarcoidosis from a pulmonary perspective.
@en
P2093
Antje Prasse
Armin Buchwald
Christine Katic
Joachim Müller-Quernheim
Martin Germann
P2860
P304
P356
10.1164/RCCM.200705-742OC
P407
P577
2007-11-01T00:00:00Z